on August 28, 2012 |
Permalink
Topics: Surgical Oncology, Oncology, Service Lines, Lung Cancer, Tumor Site Strategy, Outcomes, Quality, Performance Improvement
Megan Bailey, Oncology Roundtable
Six new hospitals have joined the Commission on Cancer’s ProvenCare Lung Cancer Collaborative, doubling the number of sites participating in the pilot study.
Started in 2010, the Lung Cancer Collaborative uses Geisinger Health Care's ProvenCare model to provide evidence-based treatment for patients with non-small cell lung cancer (NSCLC) who are candidates for lung resections. Participating hospitals provide treatment according to a care pathway containing 38 standardized elements provided by interdisciplinary teams from the preoperative to postoperative period.
Continue reading:
ProvenCare Lung Cancer Collaborative expands to six new sites
on August 6, 2012 |
Permalink
| Comments (1)
Topics: Radiation Therapy, Oncology, Service Lines, Surgical Oncology, Prostate Cancer, Tumor Site Strategy
Megan Bailey, Oncology Roundtable
A new study published in the Journal of Clinical Oncology found that prostate cancer patients seen by multidisciplinary teams are more likely to choose active surveillance than those seen by specialists in one-on-one settings.
The Massachusetts General Hospital study showed that the rate of men choosing active surveillance over aggressive treatment was nearly double for those seen in multidisciplinary clinics (43% and 22%, respectively). Correspondingly, the number of men treated with radical prostatectomy or radiation therapy decreased by 30%.
Continue reading:
Multidisciplinary teams reduce bias in prostate cancer treatment planning
on May 18, 2011 |
Permalink
Topics: Prostate Cancer, Tumor Site Strategy, Oncology, Service Lines, Surgical Oncology
My colleague Matt Garabrant just wrote this analysis of a new study from NEJM, and I thought it would be of interest.
At first blush, a study recently published in the New England Journal of Medicine provides slightly contrarian findings about the benefits of using surgery for treatment of early stage prostate cancer in men under 65. There has been a great deal of discussion about the perceived over-treatment of prostate cancer in the US, specifically focusing on the use of surgery and robotic surgery for patients who could potentially be well-served by watchful waiting.
This new study, performed by the University Hospital in Uppsala, Sweden, indicates that there was a significant reduction in the rate of death from prostate cancer in the study group that received radical prostatectomy, as compared to the group that received active surveillance. With other recent studies suggesting questionable benefits of surgery over watchful waiting for management of patients with early stage disease, there is still a lack of consensus on the appropriate way to balance the use of these treatment approaches.
Continue reading:
Debate Continues Over Role of Surgery for Early Stage Prostate Cancer
